- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $99.85M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $101.2M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $6.25M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $6.25M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $41.7M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $39.34M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −$89.98M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$105.93M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | −$36.03M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $48.47M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $51.51M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $208.21M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $224.57M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $68.68M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $68.13M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $123.38M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $122.37M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 34.62M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $4.09M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $83K |
| Capex | Q1 2025 · Mar 31, 2024 | $704K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $7.37M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.12 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.12 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $22.93M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$4.16M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $10.43M |
| Revenue | Q1 2025 · Mar 31, 2024 | $46.8M |